Then it’s kind of a mystery to try to figure out why and how they’re related.” The Riemann hypothesis has proved to be a font ...

GREENSBORO, N.C. — Taxes are all about numbers, and each year, millions of math errors are caught by the IRS. For this tax season, taxpayers will now receive letters from the IRS detailing where they ...

I serve as the rector of Holy Cross in downtown Shreveport. We also operate a day shelter down the street at Holy Cross Hope House. Since 2019, our “deposit-first” ministry has housed over 500 people.

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. The Honolulu Star-Advertiser welcomes all opinions. Want ...

To the editor: In an opinion published Monday, April 27 and titled: “America is losing its most valuable resource: People,” columnist George Will quotes another expert conservative thinker for a ...

To the editor: RFK Jr. said this: “A Democratic senator claimed it’s mathematically impossible to have a drug drop by 600%. I said, ‘Well, if the drug was $100 and it raises to $600, that would be a ...

In the United States, facilities that manufacture drugs must implement quality systems that comply with current good manufacturing practice (cGMP) regulations in 21 CFR Parts 210 and 211. While cGMP ...

U.S. military aircraft names utilize letters to designate the aircraft's primary purpose or role. The designation system evolved from cumbersome multi-letter classifications (e.g., "PW" for pursuit, ...

AI can help job seekers with résumés, cover letters, and networking. Still, there are some things to avoid when using ChatGPT and other AI tools. Job-search experts say to be detailed in your prompts ...

A woke Canadian academic whose research includes working with young children to create “queer- and trans-centered spaces” is drawing mockery online for his choice of pronouns — his full name, all ...

In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after drugmakers for marketing glucagon-like peptide-1 (GLP-1) receptor agonists and ...